Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
MA10 - Updates in Thymoma
- 14:45 - 15:45
- 8/08/2022
- Location: Hall C8
- Not for CME Credit
- Type: Mini Oral
- Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies
- Moderators:Noboru Yamamoto, Paul J Van Houtte
-
+
Session Moderator
15:22 - 15:27 | Presenter: Noboru Yamamoto
- Abstract
Loading... -
+
Session Moderator
15:22 - 15:27 | Presenter: Paul J Van Houtte
- Abstract
Loading... -
+
MA10.01 - Session Introduction
14:45 - 14:46 | Presenter: Noboru Yamamoto
- Abstract
Loading... -
+
MA10.02 - Session Introduction
14:46 - 14:47 | Presenter: Paul J Van Houtte
- Abstract
Loading... -
+
MA10.03 - Is Thoracoscopic Thymectomy Safe and Oncologically Sound in Large Thymic Tumors?
14:47 - 14:52 | Presenter: Karthik Venkataramani
- Abstract
Loading... -
+
MA10.04 - Long-term Follow-up Study of Thymic Epithelial Tumors. Report of the Updated Nation-wide Database in Japan
14:52 - 14:57 | Presenter: Meinoshin Okumura
- Abstract
Loading... -
+
MA10.05 - High Levels of CD47 Expression in Thymic Epithelial Tumors
14:57 - 15:02 | Presenter: Thomas Yang Sun
- Abstract
Loading... -
+
MA10.06 - Discussant
15:02 - 15:12 | Presenter: Joachim G.J.V. Aerts
- Abstract
Loading... -
+
MA10.07 - Phase II Trial of Sunitinib in Patients with Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines - STYLE Trial (NCT03449173)
15:12 - 15:17 | Presenter: Claudia Proto
- Abstract
Loading... -
+
MA10.08 - Activated Pathways of Myastenia Gravis in Thymic Epithelial (TETs)
15:17 - 15:22 | Presenter: Jose Carlos Benítez
- Abstract
Loading... -
+
MA10.09 - Outcomes of Induction Therapy Followed by Surgical Resection for Advanced Thymic Tumor
15:22 - 15:27 | Presenter: Sumin Shin
- Abstract
Loading... -
+
MA10.10 - Discussant
15:27 - 15:37 | Presenter: Alessandra Curioni-Fontecedro
- Abstract
Loading... -
+
MA10.11 - Live Q&A
15:37 - 15:45
- Abstract
Loading...
